Description

Oddity Tech: An Insight Into AI Skin Analysis, Proprietary Molecules, Dermatology Entry & Long-Term Category White Space!

ODDITY delivered a strong third-quarter performance in 2025, characterized by 24% year-over-year revenue growth to $148 million and 24% growth in adjusted diluted earnings per share. The company continued to outperform industry peers due to the strength of its direct-to-consumer model and an emphasis on high-efficacy beauty and wellness products. Gross margins expanded to 71.6%, up 170 basis points from the prior year, despite higher tariffs, driven by cost efficiencies and favorable mix. Adjusted EBITDA rose to $29 million, exceeding guidance, while free cash flow for the first nine months reached $90 million. ODDITY ended the quarter with $793 million in cash and investments, plus $200 million in undrawn credit, giving it substantial financial flexibility. Management raised full-year 2025 guidance, now expecting 24%–25% revenue growth to approximately $806–$809 million and gross margins near 72.5%, with adjusted EPS between $2.10 and $2.12.